Patents by Inventor Mirjam Epping

Mirjam Epping has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combined use of PRAME inhibitors and HDAC inhibitors
    Patent number: 8969544
    Abstract: The invention relates to the cancer antigen PRAME (PReferentially expressed Antigen in MElanoma) and its use in a method of treatment of a tumour which comprises administering to a subject in need of treatment an effective amount of an inhibitor of PRAME, in combination with a second agent selected from the group of an inhibitor of HDAC (an HDACi) and a retinoid.
    Type: Grant
    Filed: March 10, 2011
    Date of Patent: March 3, 2015
    Inventors: René Bernards, Mirjam Epping, Liming Wang
  • COMBINED USE OF PRAME INHIBITORS AND HDAC INHIBITORS
    Publication number: 20130123327
    Abstract: The invention relates to the cancer antigen PRAME (PReferentially expressed Antigen in MElanoma) and its use in a method of treatment of a tumour which comprises administering to a subject in need of treatment an effective amount of an inhibitor of PRAME, in combination with a second agent selected from the group of an inhibitor of HDAC (an HDACi) and a retinoid.
    Type: Application
    Filed: March 10, 2011
    Publication date: May 16, 2013
    Inventors: René Bernards, Mirjam Epping, Liming Wang
  • Combined use of PRAME inhibitors and HDAC inhibitors
    Patent number: 7928081
    Abstract: The invention relates to the cancer antigen PRAME (PReferentially expressed Antigen in MElanoma) and its use in a method of treatment of a tumour which comprises administering to a subject in need of treatment an effective amount of an inhibitor of PRAME, in combination with a second agent selected from the group of an inhibitor of HDAC (an HDACi) and a retinoid.
    Type: Grant
    Filed: January 27, 2005
    Date of Patent: April 19, 2011
    Inventors: René Bernards, Mirjam Epping, Liming Wang
  • Combined Use of Prame Inhibitors and Hdac Inhibitors
    Publication number: 20080119424
    Abstract: The invention relates to the cancer antigen PRAME (PReferentially expressed Antigen in MElanoma) and its use in a method of treatment of a tumour which comprises administering to a subject in need of treatment an effective amount of an inhibitor of PRAME, in combination with a second agent selected from the group of an inhibitor of HDAC (an HDACi) and a retinoid.
    Type: Application
    Filed: January 27, 2005
    Publication date: May 22, 2008
    Inventors: Rene Bernards, Mirjam Epping, Liming Wang